Form 4: Elanco EVP Acquires Deferred Stock Units

Elanco Animal Health Inc's Executive Vice President, Rajeev A. Modi, acquired 76.7564 deferred stock units at a price of $18.43 per unit.

Summary

• Rajeev A. Modi, Executive Vice President U.S. Pet Health and Global Digital Transformation at Elanco Animal Health Inc., acquired 76.7564 Deferred Stock Units (DSUs).
• The transaction occurred on September 5, 2025.
• Each DSU represents the right to receive one share of Elanco common stock or its cash equivalent.
• The acquisition price for the derivative security was $18.43 per unit.
• Following this transaction, Mr. Modi beneficially owns 6,891.0464 DSUs directly.
• These DSUs are set to settle in cash or shares of company common stock upon termination of employment or during a specified future year, as per the Executive Deferral and Stock Match Plan.

Sentiment

Score: 7

Explanation: The acquisition of deferred stock units by an executive is generally a positive signal, indicating confidence in the company's future. It's a routine compensation event, not a major strategic announcement, hence a moderately positive score.

Positives

• Insider acquisition of deferred stock units can signal management's confidence in the company's future performance.
• The increase in beneficial ownership aligns management's interests with those of shareholders.

Future Outlook

The filing indicates that the deferred stock units will settle in cash or shares of company common stock following termination of employment or during a specified future year, in accordance with the Executive Deferral and Stock Match Plan.

Industry Context

This transaction is a routine insider compensation event within the animal health industry, reflecting standard executive deferral plans. It does not provide specific insights into broader industry trends or competitive dynamics beyond the company's internal compensation structure.

Comparison to Industry Standards

• The acquisition of deferred stock units as part of an executive compensation plan is a common practice across various industries, including animal health.
• Companies like Zoetis Inc. (ZTS) and IDEXX Laboratories, Inc. (IDXX) also utilize similar equity-based compensation structures to align executive incentives with shareholder value.
• The specific terms, such as the number of units and vesting schedule, are typically tailored to individual company performance and executive roles, making direct comparisons of specific unit numbers less meaningful without full compensation plan details.

Related Party Transactions

• Rajeev A. Modi, an Executive Vice President of Elanco Animal Health Inc., acquired deferred stock units from the company as part of an executive compensation plan.

Stakeholder Impact

• Shareholders: May view the insider acquisition as a positive sign of management's belief in the company's future, potentially boosting investor confidence.
• Employees: No direct impact on general employees, but reflects the company's executive compensation practices.
• Management: The acquisition increases Mr. Modi's vested interest in the company's long-term performance, aligning his financial incentives with shareholder value.

Next Steps

• The deferred stock units will settle in cash or shares of Elanco common stock upon termination of employment or during a specified future year, as per the Executive Deferral and Stock Match Plan.

Key Dates

Recommendation

This Form 4 filing details a routine acquisition of deferred stock units by an executive as part of their compensation plan. While it signals management's continued alignment with shareholder interests and confidence in the company, it does not present new fundamental information or a significant change in the company's operational or financial outlook that would warrant a change from a 'hold' position based solely on this filing. It's a standard disclosure rather than a catalyst for a strong buy or sell.

Keywords

Elanco Animal Health, ELAN, Rajeev A. Modi, Insider Trading, Form 4, Deferred Stock Units, Executive Compensation, Stock Acquisition, Animal Health